Capital Southwest Announces Receipt of Second SBIC License
DALLAS, April 21, 2025 (GLOBE NEWSWIRE) — Capital Southwest Corporation ('Capital Southwest') (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced its wholly owned subsidiary, Capital Southwest SBIC II, LP ('SBIC II'), has received a license from the U.S. Small Business Administration ('SBA') to operate as a Small Business Investment Company ('SBIC').
As an SBIC, SBIC II will be subject to a variety of regulations and oversight by the SBA concerning, among other things, the size and nature of the companies in which it may invest as well as the structure of those investments. The SBIC license will allow SBIC II to obtain leverage by issuing SBA-guaranteed debentures, subject to the issuance of a leverage commitment by the SBA. SBA debentures are loans issued to an SBIC which have interest payable semi-annually and a ten-year maturity. The interest rate is fixed shortly after issuance at a market-driven spread over U.S. Treasury Notes with ten-year maturities. Current SBA regulations permit SBIC II to borrow up to $175 million in SBA-guaranteed debentures, bringing Capital Southwest's aggregate borrowing capacity through the SBIC program to a total of up to $350 million of capital.
The SBA program has played a pivotal role within Capital Southwest's lower middle market investment strategy since receiving its first SBIC license in April 2021. Capital Southwest received exemptive relief from the Securities and Exchange Commission that allows for the exclusion of SBA-guaranteed debentures from the definition of senior securities in the asset coverage requirement applicable to the Company.
About Capital Southwest
Capital Southwest Corporation (Nasdaq: CSWC) is a Dallas, Texas-based, internally managed business development company with approximately $1.7 billion in investments at fair value as of December 31, 2024. Capital Southwest is a middle market lending firm focused on supporting the acquisition and growth of middle market businesses with $5 million to $50 million investments across the capital structure, including first lien, second lien and non-control equity co-investments. As a public company with a permanent capital base, Capital Southwest has the flexibility to be creative in its financing solutions and to invest to support the growth of its portfolio companies over long periods of time.
Investor Relations Contact:
Michael S. Sarner, President and Chief Executive Officer
214-884-3829
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Evercore adds Affirm to its Tactical Underperform list
-- Evercore ISI added Affirm Holdings (NASDAQ:AFRM) to its Tactical Underperform (TAP) list, citing stretched valuations and the stock's sharp rally heading into next week's earnings. Affirm shares have surged 115% since April and 18% since the start of August, making it the best performer year-to-date under Evercore's coverage. Analysts said the run-up leaves 'the risk/reward less favorable heading into next week's print than it was a few weeks ago.' The broker highlighted that Affirm is trading near its recent peak valuation of high-20s next twelve months (NTM) EV/EBITDA, while management's traditionally cautious stance limits the likelihood of guidance exceeding consensus estimates. Still, Evercore maintained its Outperform rating on the stock, describing the TAP call as tactical rather than a change in its longer-term view. 'We still believe AFRM has the best risk platform in the space and will benefit over the longer-term from penetration in new verticals and geographies as well as product expansion,' the analysts led by Adam Frisch wrote. Investors are awaiting Affirm's fiscal fourth-quarter earnings on Aug. 28, when management will outline fiscal 2026 guidance. Evercore expects guidance to be broadly in line with consensus, with gross merchandise volume (GMV) seen growing 27% ex-Walmart and revenue less transaction costs (RLTC) margin at 3.9%. The firm noted risks tied to potential GMV declines at Walmart (NYSE:WMT), which accounts for about 5% of Affirm's volume, after competitor Klarna expanded its OnePay offering. Analysts also pointed to a margin dynamic. Notably, lower Walmart volumes could prove accretive given the partnership's lower economics, though this might be offset by the continued growth in 0% annual percentage rate (APR) loans. Over the past four quarters, Affirm has averaged a Revenue Less Transaction (JO:NTUJ) Costs (RLTC) margin of 4.1%, above management's 3-4% target. 'We expect a 3.9% RLTC margin for FY26 (down 14bps YoY and in line with consensus) but note that could prove a little conservative with continued execution,' analysts said. Related articles Evercore adds Affirm to its Tactical Underperform list After soaring 149%, this stock is back in our AI's favor - & already +25% in July 7 Undervalued Stocks on the Rise With 50%+ Upside Potential Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
9 minutes ago
- Yahoo
What Makes Mama's Creations (MAMA) a Compelling Investment?
Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the same can be downloaded here. The fund gained 28.13% in the second quarter, compared to an 8.50% increase for the Russell 2000 Index and a 15.51% increase for the Russell Microcap Index. The firm focuses on the company fundamentals, not on quarterly stock price performance. The firm invested over 80% of net asset value in the top five names. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Immersion Investment Partners highlighted stocks such as Mama's Creations, Inc. (NASDAQ:MAMA). Mama's Creations, Inc. (NASDAQ:MAMA) manufactures and markets fresh deli-prepared foods. The one-month return of Mama's Creations, Inc. (NASDAQ:MAMA) was -11.30%, and its shares lost 0.97% of their value over the last 52 weeks. On August 18, 2025, Mama's Creations, Inc. (NASDAQ:MAMA) stock closed at $8.16 per share, with a market capitalization of $306.903 million. Immersion Investment Partners stated the following regarding Mama's Creations, Inc. (NASDAQ:MAMA) in its second quarter 2025 investor letter: "Mama's Creations, Inc. (NASDAQ:MAMA): Occasionally you run across an executive who is so outlandishly passionate about their job and the brand they represent, you can't help but take notice. We first met Adam Michaels (CEO of MAMA) more than a year ago at an investor conference. Clad in mulberry shoes and sport coat, the exact brand colors of MAMA, he told us how he would take what was historically a subscale meatball manufacturer in suburban New Jersey and make it into one of the largest prepared foods and deli brands in the world. Frankly, we thought he had too many screws loose. Nonetheless, we were intrigued by the business and the category. Fresh and prepared foods in grocery stores has been a growing category, catalyzed by consumer demand for healthier, fast, and affordable food options. Grocery stores have been increasingly dedicating more food space to the category. Today, it is one of only a couple of categories that are seeing volume growth. Mama's Creations, Inc. (NASDAQ:MAMA) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 7 hedge fund portfolios held Mama's Creations, Inc. (NASDAQ:MAMA) at the end of the first quarter, which was 8 in the previous quarter. Mama's Creations, Inc.'s (NASDAQ:MAMA) fiscal Q1 2026 revenue grew approximately 18% year over year, to a record $35.3 million. While we acknowledge the potential of Mama's Creations, Inc. (NASDAQ:MAMA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned approximately +14% net of fees and expenses, bringing the YTD returns to under +1%. YTD, the Russell 2000 has returned -1.8%. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Greenhaven Road Capital highlighted stocks such as Lifecore Biomedical, Inc. (NASDAQ:LFCR). Lifecore Biomedical, Inc. (NASDAQ:LFCR) is an integrated contract development and manufacturing organization. The one-month return of Lifecore Biomedical, Inc. (NASDAQ:LFCR) was -0.54%, and its shares gained 30.05% of their value over the last 52 weeks. On August 18, 2025, Lifecore Biomedical, Inc. (NASDAQ:LFCR) stock closed at $7.40 per share, with a market capitalization of $276.818 million. Greenhaven Road Capital stated the following regarding Lifecore Biomedical, Inc. (NASDAQ:LFCR) in its second quarter 2025 investor letter: "Another holding that I believe has a high expected value is Lifecore Biomedical, Inc. (NASDAQ:LFCR), which I have written about extensively. Here is a link to a recent presentation (link) I did for the investing platform SumZero. Kyle and I visited the manufacturing facility in Minnesota during the quarter and spent time with management and the business development team. As a reminder, LifeCore is a contract drug manufacturer which has recently added significant manufacturing capacity. They are operating at approximately 20% of their capacity with 15% EBITDA margins. A village pharmacist fulfilling a patient's medication prescription in a rural area. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 12 hedge fund portfolios held Lifecore Biomedical, Inc. (NASDAQ:LFCR) at the end of the first quarter compared to 10 in the previous quarter. While we acknowledge the potential of Lifecore Biomedical, Inc. (NASDAQ:LFCR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Lifecore Biomedical, Inc. (NASDAQ:LFCR) and shared Laughing Water Capital's views on the company. Greenhaven Road Capital increased its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR) in the previous quarter to nearly 10%. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
